Helicobacter pylori in colorectal neoplasms: Is there an aetiological relationship?

被引：63

作者：

Jones M. ^{[1
]}

Helliwell P. ^{[1
]}

Pritchard C. ^{[2
]}

Tharakan J. ^{[3
]}

Mathew J. ^{[1
]}

机构：

[1] Department of Histopathology, Royal Cornwall Hospital

[2] Department of Research and Development, Royal Cornwall Hospital

[3] Department of Medicine, Princess Alexandra Hospital, Harlow, Essex

来源：

World Journal of Surgical Oncology | / 5卷 / 1期

关键词：

Adenoma; Colorectal Adenocarcinoma; Aberrant Crypt Focus; Colorectal Neoplasia; Villous Adenoma;

D O I：

10.1186/1477-7819-5-51

中图分类号：

学科分类号：

摘要：

Background: This pilot study was carried out to determine whether Helicobacter pylori can be detected in normal colon or in association with colorectal neoplasia. Methods: Paraffin processed colonic tissue blocks of normal colonic mucosa (n = 60), and patients diagnosed as adenoma (n = 60), and adenocarcinoma (n = 60) were retrieved from our archive; the adenoma group included tubular (n = 20), tubulovillous (n = 20) and villous adenomas (n = 20). 4 μm sections were stained by immunohistochemical methods using anti-Helicobacter pylori antibodies (polyclonal NCL-HPp and monoclonal NCL-C-jejuni). Results: Significant numbers of Helicobacter pylori were identified in tubular adenomas (OR = 11.13; 95%CI = 1.62-76.70), tubulovillous adenomas (OR = 10.45; 95%CI = 1.52-71.52) and adenocarcinomas (OR = 8.13; 95%CI = 1.40-46.99) compared to controls: there was no association in numbers of Helicobacter pylori and villous adenomas (OR = 2.95; 95%CI = 0.29-9.96). Conclusion: We conclude that although, in this pilot study, there appears to be an association in the prevalence of Helicobacter pylori with some, but not all, colorectal neoplasms, we can not infer causality from these results. These findings need to be further substantiated with a prospective study and the use of molecular biological techniques to determine a causal association. © 2007 Jones et al; licensee BioMed Central Ltd.

引用

共 54 条

[51]

Hartwich A., Konturek S.J., Pierzchalski P., Zuchowicz M., Labza H., Konturek P.C., Karczewska E., Bielanski W., Marlicz K., Starzynska T., Lawniczak M., Hahn E.G., Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer, Int J Colorectal Dis, 16, pp. 202-210, (2001)

[52]

Rao V.P., Poutahidis T., Ge Z., Nambiar P.R., Boussahmain C., Wang Y.Y., Horwitz B.H., Fox J.G., Erdman S.E., Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice, Cancer Res, 66, pp. 7395-7400, (2006)

[53]

Erdman S.E., Poutahidis T., Tomczak M., Rogers A.B., Cormier K., Plank B., Horwitz B.H., Fox J.G., CD4+ CD25+ Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice, Am J Pathol, 162, pp. 691-702, (2003)

[54]

Novocastra Laboratories Data Sheet. Helicobacter pylori, rabbit polyclonal antibody, NCL-HPp

← 1 2 3 4 5 6 →